These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

702 related items for PubMed ID: 19642182

  • 1. In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: results from the Leiden MISSION! acute myocardial infarction treatment optimization program.
    Hassan AK, Liem SS, van der Kley F, Bergheanu SC, Wolterbeek R, Bosch J, Bootsma M, Zeppenfeld K, van der Laarse A, Atsma DE, Jukema JW, Schalij MJ.
    Catheter Cardiovasc Interv; 2009 Aug 01; 74(2):335-43. PubMed ID: 19642182
    [Abstract] [Full Text] [Related]

  • 2. Aspiration thrombectomy during primary percutaneous coronary intervention as adjunctive therapy to early (in-ambulance) abciximab administration in patients with acute ST elevation myocardial infarction: an analysis from Leiden MISSION! acute myocardial infarction treatment optimization program.
    Ahmed TA, Atary JZ, Wolterbeek R, Hasan-Ali H, Abdel-Kader SS, Schalij MJ, Jukema JW.
    J Interv Cardiol; 2012 Feb 01; 25(1):1-9. PubMed ID: 22059390
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention.
    Bellandi F, Maioli M, Gallopin M, Toso A, Dabizzi RP.
    Catheter Cardiovasc Interv; 2004 Jun 01; 62(2):186-92. PubMed ID: 15170708
    [Abstract] [Full Text] [Related]

  • 6. Effects of early abciximab administration before primary percutaneous coronary intervention on left ventricular function assessed by cardiac magnetic resonance.
    Rakowski T, Mielecki W, Brzozowska-Czarnek A, Dziewierz A, Siudak Z, Legutko J, Rzeszutko L, Urbanik A, Dubiel JS, Dudek D.
    Kardiol Pol; 2008 Jun 01; 66(6):617-22; discussion 623. PubMed ID: 18626830
    [Abstract] [Full Text] [Related]

  • 7. Early abciximab use in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention improves long-term outcome. Data from EUROTRANSFER Registry.
    Siudak Z, Rakowski T, Dziewierz A, Janzon M, Birkemeyer R, Stefaniak J, Partyka Ł, Zmudka K, Dudek D.
    Kardiol Pol; 2010 May 01; 68(5):539-43. PubMed ID: 20491016
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in diabetic patients with ST-segment elevation myocardial infarction (EUROTRANSFER Registry).
    Dziewierz A, Mielecki W, Siudak Z, Rakowski T, Janzon M, Birkemeyer R, Zasada W, Dubiel JS, Dudek D.
    Atherosclerosis; 2012 Jul 01; 223(1):212-8. PubMed ID: 22658254
    [Abstract] [Full Text] [Related]

  • 10. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
    Gu YL, Kampinga MA, Wieringa WG, Fokkema ML, Nijsten MW, Hillege HL, van den Heuvel AF, Tan ES, Pundziute G, van der Werf R, Hoseyni Guyomi S, van der Horst IC, Zijlstra F, de Smet BJ.
    Circulation; 2010 Dec 21; 122(25):2709-17. PubMed ID: 21098442
    [Abstract] [Full Text] [Related]

  • 11. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
    Thiele H, Schindler K, Friedenberger J, Eitel I, Fürnau G, Grebe E, Erbs S, Linke A, Möbius-Winkler S, Kivelitz D, Schuler G.
    Circulation; 2008 Jul 01; 118(1):49-57. PubMed ID: 18559698
    [Abstract] [Full Text] [Related]

  • 12. Incidence, patient characteristics and predictors of aborted myocardial infarction in patients undergoing primary PCI: prospective study comparing pre- and in-hospital abciximab pretreatment.
    Hassan AK, Jukema JW, van der Laarse A, Hasan-Ali H, Wolterbeek R, van der Kley F, Spano F, Atsma DE, Schalij MJ.
    EuroIntervention; 2009 Mar 01; 4(5):662-8. PubMed ID: 19378689
    [Abstract] [Full Text] [Related]

  • 13. Prospective randomised study to evaluate effectiveness of distal embolic protection compared to abciximab administration in reduction of microembolic complications of primary coronary angioplasty.
    Ochała A, Smolka G, Wojakowski W, Gabrylewicz B, Garbocz P, Tendera M.
    Kardiol Pol; 2007 Jun 01; 65(6):672-80; discussion 681-3. PubMed ID: 17629829
    [Abstract] [Full Text] [Related]

  • 14. Intracoronary compared to intravenous Abciximab and high-dose bolus compared to standard dose in patients with ST-segment elevation myocardial infarction undergoing transradial primary percutaneous coronary intervention: a two-by-two factorial placebo-controlled randomized study.
    Bertrand OF, Rodés-Cabau J, Larose E, Rinfret S, Gaudreault V, Proulx G, Barbeau G, Déry JP, Gleeton O, Manh-Nguyen C, Noël B, Roy L, Costerousse O, De Larochellière R, EArly Discharge after Transradial Stenting of CoronarY Arteries in Acute Myocardial Infarction (EASY-MI) Study Investigators.
    Am J Cardiol; 2010 Jun 01; 105(11):1520-7. PubMed ID: 20494655
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Periprocedural abciximab administration in ST elevation myocardial infarction patients. Effect on severe microvascular obstruction beyond the restoration of epicardial coronary flow by primary angioplasty.
    Tarantini G, Ramondo A, Corbetti F, Perazzolo Marra M, Cacciavillani L, Napodano M, Bilato C, Razzolini R, Iliceto S.
    Cardiology; 2008 Jun 01; 110(2):129-34. PubMed ID: 17971662
    [Abstract] [Full Text] [Related]

  • 17. Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in elderly patients transferred with ST-elevation myocardial infarction: data from the EUROTRANSFER registry.
    Dziewierz A, Siudak Z, Rakowski T, Chyrchel M, Mielecki W, Janzon M, Birkemeyer R, Tierala I, Wojdyła RM, Dubiel JS, Dudek D.
    Int J Cardiol; 2010 Aug 20; 143(2):147-53. PubMed ID: 19559491
    [Abstract] [Full Text] [Related]

  • 18. Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial).
    Taglieri N, Saia F, Guiducci V, Tondi S, Conrotto F, Marrozzini C, Rocchi G, Biagini E, Reggiani ML, Giacometti P, Piovaccari G, Manari A, Marzocchi A, FATA Trial Investigators.
    Am J Cardiol; 2009 Mar 15; 103(6):785-90. PubMed ID: 19268732
    [Abstract] [Full Text] [Related]

  • 19. Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial).
    Maioli M, Bellandi F, Leoncini M, Toso A, Dabizzi RP.
    J Am Coll Cardiol; 2007 Apr 10; 49(14):1517-24. PubMed ID: 17418289
    [Abstract] [Full Text] [Related]

  • 20. Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: design and rationale of the Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) trial.
    Thiele H, Wöhrle J, Neuhaus P, Brosteanu O, Sick P, Prondzinsky R, Birkemeyer R, Wiemer M, Kerber S, Schuehlen H, Kleinertz K, Axthelm C, Zimmermann R, Rittger H, Braun-Dullaeus RC, Lauer B, Burckhardt W, Ferrari M, Bergmann MW, Hambrecht R, Schuler G, Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) Investigators.
    Am Heart J; 2010 Apr 10; 159(4):547-54. PubMed ID: 20362711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.